search
Back to results

Influence of Plantago Major on Mineral Metabolism and Selected Biochemical Parameters in Obese Women (Plantago)

Primary Purpose

Obesity

Status
Completed
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
Plantago major
Placebo
Sponsored by
Poznan University of Life Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Obesity focused on measuring Plantago major, obesity, mineral content, adipose tissue

Eligibility Criteria

18 Years - 60 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • body mass index (BMI) equal to or greater than 30 kg/m2

    • age 18 to 60 years
    • stable body weight (< 3 kg self-reported change during the previous three months)
    • written informed consent to participate in the study,
    • abdominal obesity - waist circumference> 80 cm;
    • body fat content measured by bio-impedance ≥ 33%;
    • female

Exclusion Criteria:

  • secondary obesity or secondary hypertension
  • diabetes type I
  • gastrointestinal disease;
  • dyslipidaemia, type 2 diabetes, hypertension requiring the implementation of pharmacological treatment in the last 3 months prior to observation or follow-up;
  • a history of use of any dietary supplements within the one month prior to the study
  • clinically significant acute or chronic inflammatory disease in the respiratory, gastrointestinal or genitourinary system or in the mouth, throat, paranasal sinuses and / or connective tissue disease, arthritis;
  • simultaneous participation in a study that affects body mass or use of diet / medication / nutritional behaviors affecting body mass;
  • a history of infection in the month prior to the study
  • nicotine, drug or alcohol abuse
  • or other condition that, in the opinion of the investigators, would make participation not in the best interest of the patient or could prevent, limit, or confound the study results

Sites / Locations

  • Poznan University of Life Sciences

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Placebo

Plantago major

Arm Description

Individuals receive a placebo daily, for 12 weeks.

Individuals receive Plantago major daily, for 12 weeks.

Outcomes

Primary Outcome Measures

mineral content
content of minerals in serum, urine and hair

Secondary Outcome Measures

blood pressure
blood pressure
body mass
body mass
body height
body height
hip circumference
hip circumference
waist circumference
waist circumference
body content measured by bioimpedance: % of fat tissue
Content of fat tissue measured by bioimpedance
body content measured by bioimpedance: % of muscle tissue
Content of muscle tissue measured by bioimpedance
serum total cholesterol
Serum concentration of total cholesterol
serum LDL cholesterol
Serum concentration of LDL cholesterol
serum HDL cholesterol
Serum concentration of HDL cholesterol
serum triglycerides
Serum concentration of triglycerides
insulin
insulin serum concentration
glucose
glucose serum concentration

Full Information

First Posted
February 13, 2018
Last Updated
April 4, 2022
Sponsor
Poznan University of Life Sciences
Collaborators
Poznan University of Medical Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT03439540
Brief Title
Influence of Plantago Major on Mineral Metabolism and Selected Biochemical Parameters in Obese Women
Acronym
Plantago
Official Title
The Study on the Influence of Plantago Species (Plantago Major) on Adipose Tissue Content, Mineral Metabolism and Other Selected Biochemical Parameters of Blood in Obese Women
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
March 1, 2018 (Actual)
Primary Completion Date
December 1, 2020 (Actual)
Study Completion Date
September 30, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Poznan University of Life Sciences
Collaborators
Poznan University of Medical Sciences

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Effect of oral supplementation with Plantago major on cardiometabolic risk factors and mineral content and lifestyle in obese women: double-blind, randomized clinical trial.
Detailed Description
The purpose of the study is to determine whether oral Plantago major supplementation affects cardiometabolic risk factors, mineral content, and lifestyle in obese women. In previous research it was found that the Plantago maxima extract counteracts the development of adipose tissue in rats on a high-fat diet. In addition, antioxidative, anti-inflammatory and antidiabetic action of Plantago has been demonstrated. Moreover, it has been shown that Plantago influences lipolysis in obese mice and ameliorates metabolic processess in obese rats. The project is due to evaluate the effect of oral supplementation with selected Plantago species - Plantago major in obese patients on: the content of minerals in blood, hair and urine total cholesterol, HDL and LDL cholesterol and triglycerides blood concentration, blood glucose and insulin concentration, blood pressure, anthropometric parameters: body mass, body height, waist and hip circumferences body content measured by bioimpedance: % of fat tissue and % of muscle tissue quality of life 70 subjects will be randomized into two groups and receive oral Plantago major extract (the first group) or oral placebo (the second group) once daily for 12 weeks. At baseline and at completion (after 12 weeks) fasting blood, urine and hair samples will be collected and abovementioned parameters will be measured.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
Plantago major, obesity, mineral content, adipose tissue

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
70 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Individuals receive a placebo daily, for 12 weeks.
Arm Title
Plantago major
Arm Type
Experimental
Arm Description
Individuals receive Plantago major daily, for 12 weeks.
Intervention Type
Dietary Supplement
Intervention Name(s)
Plantago major
Intervention Description
Individuals receive Plantago major daily, for 12 weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Individuals receive placebo daily, for 12 weeks
Primary Outcome Measure Information:
Title
mineral content
Description
content of minerals in serum, urine and hair
Time Frame
At the baseline and following 12 weeks of treatment
Secondary Outcome Measure Information:
Title
blood pressure
Description
blood pressure
Time Frame
At the baseline and following 12 weeks of treatment
Title
body mass
Description
body mass
Time Frame
At the baseline and following 12 weeks of treatment
Title
body height
Description
body height
Time Frame
At the baseline and following 12 weeks of treatment
Title
hip circumference
Description
hip circumference
Time Frame
At the baseline and following 12 weeks of treatment
Title
waist circumference
Description
waist circumference
Time Frame
At the baseline and following 12 weeks of treatment
Title
body content measured by bioimpedance: % of fat tissue
Description
Content of fat tissue measured by bioimpedance
Time Frame
At the baseline and following 12 weeks of treatment
Title
body content measured by bioimpedance: % of muscle tissue
Description
Content of muscle tissue measured by bioimpedance
Time Frame
At the baseline and following 12 weeks of treatment
Title
serum total cholesterol
Description
Serum concentration of total cholesterol
Time Frame
At the baseline and following 12 weeks of treatment
Title
serum LDL cholesterol
Description
Serum concentration of LDL cholesterol
Time Frame
At the baseline and following 12 weeks of treatment
Title
serum HDL cholesterol
Description
Serum concentration of HDL cholesterol
Time Frame
At the baseline and following 12 weeks of treatment
Title
serum triglycerides
Description
Serum concentration of triglycerides
Time Frame
At the baseline and following 12 weeks of treatment
Title
insulin
Description
insulin serum concentration
Time Frame
At the baseline and following 12 weeks of treatment
Title
glucose
Description
glucose serum concentration
Time Frame
At the baseline and following 12 weeks of treatment

10. Eligibility

Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: body mass index (BMI) equal to or greater than 30 kg/m2 age 18 to 60 years stable body weight (< 3 kg self-reported change during the previous three months) written informed consent to participate in the study, abdominal obesity - waist circumference> 80 cm; body fat content measured by bio-impedance ≥ 33%; female Exclusion Criteria: secondary obesity or secondary hypertension diabetes type I gastrointestinal disease; dyslipidaemia, type 2 diabetes, hypertension requiring the implementation of pharmacological treatment in the last 3 months prior to observation or follow-up; a history of use of any dietary supplements within the one month prior to the study clinically significant acute or chronic inflammatory disease in the respiratory, gastrointestinal or genitourinary system or in the mouth, throat, paranasal sinuses and / or connective tissue disease, arthritis; simultaneous participation in a study that affects body mass or use of diet / medication / nutritional behaviors affecting body mass; a history of infection in the month prior to the study nicotine, drug or alcohol abuse or other condition that, in the opinion of the investigators, would make participation not in the best interest of the patient or could prevent, limit, or confound the study results
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joanna Suliburska, Assoc. Prof.
Organizational Affiliation
Poznan University of Life Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Poznan University of Life Sciences
City
Poznań
ZIP/Postal Code
60-624
Country
Poland

12. IPD Sharing Statement

Learn more about this trial

Influence of Plantago Major on Mineral Metabolism and Selected Biochemical Parameters in Obese Women

We'll reach out to this number within 24 hrs